Kirsten L. Gruis's Insider Trades & SAST Disclosures

Kirsten L. Gruis's most recent trade in DiaMedica Therapeutics Inc was a trade of 67,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 1, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
DiaMedica Therapeutics Inc
Kirsten L. Gruis Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 67,000 67,000 - - Stock Option (right to buy)
DiaMedica Therapeutics Inc
Kirsten L. Gruis Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 160,000 160,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades